Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 14/20 | 0.46 |
| ▸ | FNTB | P49356 | 14/20 | 0.46 |
| ▸ | PGGT1B | P53609 | 11/20 | 0.46 |
| ▸ | CCR2 | P41597 | 1/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | CCR5 | P51681 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8097834 | 0.86 | FNTA (0.47) | FNTAFNTBPGGT1BCCR2CYP11B1 | |
| SCHEMBL8097836 | 0.86 | FNTA (0.47) | FNTAFNTBPGGT1BCCR2CYP11B1 | |
| SCHEMBL8090861 | 0.86 | FNTA (0.53) | FNTAFNTBPGGT1BKCNH2 | |
| SCHEMBL8090860 | 0.86 | FNTA (0.53) | FNTAFNTBPGGT1BKCNH2 | |
| SCHEMBL8440169 | 0.84 | FNTA (0.51) | FNTAFNTBPGGT1BCYP11B1CYP11B2 | |
| SCHEMBL8095390 | 0.84 | FNTA (0.51) | FNTAFNTBPGGT1BCYP11B1CYP11B2 | |
| SCHEMBL446560 | 0.83 | FNTA (0.45) | FNTAFNTBPGGT1BCCR2CYP11B1 | |
| SCHEMBL8098299 | 0.81 | CCR5 (0.44) | FNTAFNTBPGGT1BCCR2CYP11B1 | |
| SCHEMBL8097467 | 0.80 | CCR2 (0.45) | FNTAFNTBPGGT1BCCR2CYP11B1 | |
| SCHEMBL8095468 | 0.80 | FNTA (0.43) | FNTAFNTBPGGT1BCCR2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6127366-A | ANTICARCINOGENIC OR ANTITUMOR AGENTS | MERCK & CO., INC. (US) | 2000-10-03 | — | — | US | disclosed |